Endothelin Receptor Antagonists: all 328 studies that test it
Page 4 of 4. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)TerminatedNCT00310830Phase 3
- Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers SyndromeCompletedNCT00303004Phase 3
- Correlation of Endothelial Function and Early Coronary Artery Disease in HumansCompletedNCT00271492Phase 3
- Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by HypoxiaCompletedNCT00260819Phase 1
- Treatment of Early Systemic Sclerosis by BosentanTerminatedNCT00226889Phase 1/2
- Treatment of Supine Hypertension in Autonomic FailureCompletedNCT00223717Phase 1
- Atrasentan and Zometa for Men With Prostate Cancer Metastatic to BoneCompletedNCT00181558Phase 2
- A Long Term Safety Study With AtrasentanCompletedNCT00127478Phase 2/3
- To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic NephropathyTerminatedNCT00120328Phase 3
- The Contribution of Endothelin to Vasomotor Function in Diseased Coronary ArteriesCompletedNCT00115583Not applicable
- Clazosentan in Preventing the Occurrence of Cerebral Vasospasm Following an Aneurysmal Subarachnoid Hemorrhage (aSAH)CompletedNCT00111085Phase 2
- Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class IICompletedNCT00091715Phase 3
- ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)CompletedNCT00091598Phase 3
- The Effect of Tracleer® on Male FertilityCompletedNCT00082186Phase 4
- Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial HypertensionCompletedNCT00080457Phase 3
- Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With SclerodermaCompletedNCT00077584Phase 3
- Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary FibrosisCompletedNCT00071461Phase 2/3
- Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With SclerodermaCompletedNCT00070590Phase 2/3
- YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate CancerTerminatedNCT00050297Phase 2
- YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone TherapyTerminatedNCT00048659Phase 2
- Atrasentan in Treating Patients With Prostate CancerCompletedNCT00046943Phase 3
- Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial HypertensionCompletedNCT00046319Phase 2
- Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney CancerCompletedNCT00039429Phase 2
- Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical FailureCompletedNCT00038662Phase 2
- Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate CancerCompletedNCT00036556Phase 3
- A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate CancerCompletedNCT00036543Phase 3
- Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial HypertensionStatus unknownNCT00034307Phase 2/3
- Atrasentan in Treating Patients With Progressive or Recurrent Malignant GliomaCompletedNCT00017264Phase 1